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ABSTRACT 
Objective 
To determine the clinical stage (stable, unstable, deteriorating or dying) for children and young 
people (CYP) aged 0-25 years in Scotland with a life limiting condition (LLC). 
Design 
National cohort of CYP with a LLC using linked routinely collected healthcare data. 
Setting 
Scotland. 
Patients 
20436 CYP identified as having a LLC and resident in Scotland between 1 April 2009 and 31 March 
2014 
Main Outcome 
Clinical stage based on emergency inpatient and intensive care unit admissions and date of death. 
Results 
Over 2200 CYP with a LLC in Scotland were unstable, deteriorating or dying in each year. Compared 
to 1-5 year olds, under 1s had highest risk of instability (OR 6.4, 95% CI 5.7-7.1); all older age groups 
had lower risk. Girls were more likely to be unstable than boys (OR 1.15, 95% CI 1.06-1.24). CYP of 
South Asian (OR 1.61, 95% CI 1.28-2.01), Black (OR 1.58, 95% CI 1.04-2.41) and Other (OR 1.33, 95% 
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CI 1.02-1.74) ethnicity were more likely to experience instability than White CYP. Deprivation was 
not a significant predictor of instability. Compared to congenital abnormalities, CYP with most other 
primary diagnoses had a higher risk of instability, only CYP with a primary Perinatal diagnosis had 
significantly lower risk (OR 0.23, 95% CI 0.19-0.29).  
Conclusions 
The large number of CYP with a LLC who are unstable, deteriorating or dying may benefit from input 
from specialist pediatric palliative care. The under 1 age group and CYP of South Asian, Black and 
Other ethnicities should be priority groups. 
 
WHAT IS ALREADY KNOWN? 
National prevalence of children and young people with Life-Limiting Conditions is rising in England. 
Children and young people with Life-Limiting Conditions have complex health care needs  W often 
with repeated hospital admissions, particularly at end of life. 
 
WHAT THIS STUDY ADDS? 
In each year, over 2200 children and young people with Life-Limiting Conditions in Scotland are 
unstable, deteriorating or dying. 
Children under 1 year of age are more likely than older children to be unstable, deteriorating or 
dying. 
CYP from South Asian, Black or Other ethnic groups are more likely to be unstable, deteriorating or 
dying than White children. 
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INTRODUCTION 
The prevalence of children and young people (CYP) with a life limiting condition
1
 (LLC) is increasing, 
with numbers in England estimated to be over 40,000.
1 2
 Although many of the individual diagnoses 
are rare, as a group, CYP with a LLC represent a larger patient population than many other long term 
conditions in children (e.g. diabetes mellitus).
3
 CYP with a LLC have unpredictable disease 
trajectories, but typically have complex health care needs  W often with repeated hospital admissions, 
particularly at end of life.
4 5
 During childhood care is usually coordinated by tertiary paediatric 
ƐƉĞĐŝĂůŝƐƚƐ Žƌ ĐŽŵŵƵŶŝƚǇ ƉĂĞĚŝĂƚƌŝĐŝĂŶƐ ? ůƚŚŽƵŐŚ ƚŚĞ t,K ĚĞĨŝŶŝƚŝŽŶ ŽĨ ĐŚŝůĚƌĞŶ ?Ɛ ƉĂůůŝĂƚŝǀĞ ĐĂƌĞ 
ƐƚĂƚĞƐƚŚĂƚ ?/ƚďĞŐŝŶƐǁŚĞŶŝůůŶĞƐƐ ŝƐĚŝĂŐŶŽƐĞĚ ?ĂŶĚĐŽŶƚŝŶƵĞƐƌĞŐĂƌĚůĞƐƐŽĨǁŚĞther or not a child 
ƌĞĐĞŝǀĞƐ ƚƌĞĂƚŵĞŶƚ ĚŝƌĞĐƚĞĚ Ăƚ ƚŚĞ ĚŝƐĞĂƐĞ ?,6 paediatric palliative care specialists are often not 
involved until later in the disease process. Identifying CYP who would benefit from specialist input 
earlier may be beneficial to them and health and social care services. 
To date there has been no published research estimating the proportion of CYP with LLC who were 
not clinically stable and therefore in greater need of input from specialist paediatric palliative care 
services. This study used routinely collected national healthcare data to identify CYP with LLC in 
Scotland, their clinical stage and risk factors for instability. 
PATIENTS AND METHODS 
Definition of Life-Limiting Conditions 
Individuals with LLC were identified using a previously developed ICD-10
7
 coding framework,
2
  
further refined by removing ICD-10 codes where, in the current dataset, no individuals had died 
(information not available when the original framework was developed). 
                                                          
1
 Life Limiting Conditions (LLC) are those for which there is no reasonable hope of cure and from which 
children or young people (CYP) will ultimately die prematurely, e.g., Duchenne Muscular Dystrophy or 
neurodegenerative disease. Life-threatening conditions (LTC) are those for which curative treatment may be 
feasible but can fail, e.g. cancer. LLC will be used throughout this paper to include LLC and LTC. 
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Datasets used 
Extracts from the following routinely collected datasets were used (Supplementary Figure S1 & 
Supplementary Table S1): 
x Scottish Birth Record (SBR) 
x Scottish Morbidity Record (SMR01) - General Acute Inpatient and Day Case 
x Prescribing Information System data (available  from 2009/10) 
x Scottish Outpatient Dataset (SMR00) 
x Scottish Cancer Registry (SMR06) 
x GRO Death registration data 
x Paediatric Intensive Care Audit Network (PICANet) (available from 2007/8) 
Data access was approved by the Privacy Advisory Committee (ref: XRB14010). The Health Research 
Authority approved linkage of PICANet data with NHS National Services Scotland (NSS) data (PIAG 4-
07(c)/2002 Amendment 16 February, 2015).  
All data were analysed within the NSS Electronic Data Research and Innovation Service (eDRIS) safe 
haven.
8
 The presented results underwent disclosure control.
9
  
Data Management 
Data linkage was undertaken by the eDRIS team. A probabilistic algorithm using surname; first initial 
(forename and second initial if available); sex; year, month and day of birth; and postcode was used 
to match individuals in each dataset to the population spine dataset (CHI index) which contains 
personal identifiable data for all individuals in Scotland who have used an NHS Scotland service 
(including GP registration).
10
 False positive and false negative rates in the matching are kept close to 
1%.
10
  The datasets were then linked deterministically using the CHI number.  
There were multiple sources of demographic information. Individuals were assigned the most 
commonly recorded gender. The various ethnic groups recorded were collapsed to four main 
groups: White; South Asian (Indian, Pakistani and Bangladeshi); Black; Other (including mixed 
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ĞƚŚŶŝĐŝƚǇ ? ĂŶĚ ƚŚĞŶ ƚŚĞ ŵŽƐƚ ĐŽŵŵŽŶůǇ ƌĞĐŽƌĚĞĚ ĞƚŚŶŝĐ ŐƌŽƵƉ  ?ĞǆĐůƵĚŝŶŐ  “ŶŽƚ ŬŶŽǁŶ ? ? ǁĂƐ
assigned to each individual. Date of birth was assigned as the most commonly recorded date. 
Individuals were assigned an age group (under 1; 1-5; 6-10; 11-15; 16-20; 21-25 years) in each 
financial year based on age at the start of the first record for that year.  
Five population weighted deprivation categories, using the Scottish Index of Multiple Deprivation 
(SIMD) 2009, with 20% of the Scottish population in each category, were assigned by eDRIS using 
Data Zone  ?ƚŚĞ ^ĐŽƚƚŝƐŚ 'ŽǀĞƌŶŵĞŶƚ ?Ɛ ƉƌĞĨĞƌƌĞĚ ƐŵĂůů ŐĞŽŐƌĂƉŚǇ ĂƌĞĂ )11 of residence. SIMD is a 
national area based measure of relative deprivation which consists of 35 indicators in seven 
domains.
12
 Individuals were assigned the first deprivation category recorded each year. 
LLC diagnoses were categorized into 11 groups based on the main ICD-10 chapters: neurology, 
haematology, oncology, metabolic, respiratory, circulatory, gastrointestinal, genitourinary, perinatal, 
ĐŽŶŐĞŶŝƚĂů ?ĂŶĚ ?ŽƚŚĞƌ ? ?/ŶĚŝǀŝĚƵĂůƐŵĂǇŚĂǀĞŵŽƌĞƚŚĂŶŽŶĞ>>ĚŝĂŐŶŽƐŝƐ ?ƉƌŝŵĂƌǇĚŝĂŐŶŽƐŝƐ
category was defined as the modal diagnosis category in the first diagnostic field in SMR01 and SBR 
records for that financial year. If there was no mode, the first record for the financial year was used. 
If there was no SMR01 or SBR record in a given year, the preceding yĞĂƌ ?ƐƉƌŝŵĂƌǇĚŝĂŐŶŽƐƚŝĐŐƌŽƵƉ
was used. 
Dates of death were based on the death registration data. Other sources (SMR01, SMR06 and 
PICANet) replaced only invalid (more than a day before the last inpatient admission) or missing 
dates.  
Analyses 
All data analyses were performed using Stata version 12.
13
 
Cohort Identification 
The study cohort was defined as all individuals with a LLC resident in Scotland and aged 0-25 years 
between 1 April 2009 and 31 March 2014 (in this period, all datasets were available). To minimise 
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left edge effects (where some CYP diagnosed prior to 2009 but who were still alive and resident in 
Scotland with a LLC may be missed), LLC was assigned to an individual if any of their SBR or SMR01 
records from 1 April 2003 to 31 March 2014 contained a framework ICD-10 code. Each year, 
individuals were deemed alive and resident in Scotland if they had a record in the SBR, SMR01 or 
community prescription records. LLC prevalence per 10000 population was calculated with 
population at risk determined from census-derived mid-year estimates.
14
 95% confidence intervals 
were calculated using a normality assumption.
15
  
Clinical Stage 
Four clinical stages (stable, unstable, deteriorating and dying) in palliative/end of life patients have 
been previously defined.
16,17
 The palliative care funding review (PCFR) in England of adults and 
ĐŚŝůĚƌĞŶĂŝŵĞĚ ?ƚŽĚĞǀĞůŽƉĂĐůĂƐƐŝĨŝĐĂƚŝŽŶƐǇƐƚĞŵǁŚŝĐŚĐĂƚĞŐŽƌŝƐŝŶŐƉĂůůŝĂƚŝǀĞ ?ĞŶĚŽĨůŝĨĞƉĂƚŝĞŶƚƐŝŶ
according to level of need, which is capable of categorising palliative and end of life patients into 
ŵĞĂŶŝŶŐĨƵůŐƌŽƵƉƐďĂƐĞĚŽŶĐŽŵƉĂƌĂďůĞŝŶƚĞŶƐŝƚǇŽĨĐĂƌĞŶĞĞĚƐĂŶĚƐŝŵŝůĂƌŝƚǇŝŶƌĞƐŽƵƌĐĞƵƐĞ ? ?16 In 
the PCFR the phase of illness (clinical stage) was a subjective measure by the clinician in charge of 
care but for both adults and children this was the most important factor in determining the intensity 
of care need and resource use. In this current study we have reversed this process by defining 
clinical stage  using  an objective measure of healthcare use (Figure 1): 
x Entering unstable stage: an unplanned admission to hospital lasting > 48 hours. >48 hours 
was chosen to avoid including children who had emergency admissions for service 
availability issues (e.g. 5pm on Friday) rather than level of illness 
x Entering  deteriorating stage: an emergency admission to an ICU or PICU 
x Entering dying stage: the last 28 days before death (an arbitrary time prior to death was 
required and due to very small numbers of children and young people dying this was the 
only acceptable classification) 
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Individuals were stable when not in one of the other stages, e.g. only appearing in the prescribing 
data or only having planned inpatient hospital stays. 
The most severe clinical stage was determined for each cohort member in each financial year. 
Sensitivity analyses were undertaken, classifying individuals at 1 month, 3 month and 6 month 
intervals, and varying the transition criteria, e.g. entering unstable: any unplanned admission; 
entering deteriorating: any PICU admission requiring ventilation; entering dying: 14 days prior to 
death. These results could not be released from the safe haven due to disclosure concerns.  
The yearly percentage of cohort members in each clinical stage was calculated overall, by age group, 
deprivation category and diagnostic group. Analyses by ethnicity could not be disclosed due to small 
numbers. In each set of analyses, individuals with data missing for the variable under consideration 
were excluded. 
Statistical Modelling 
Due to small numbers, the non-stable categories were combined to create a single binary outcome 
variable (stable=0; not stable=1) for modelling. Age group, deprivation category, ethnicity, primary 
diagnostic category and gender were identified as predictors. 
The data were clustered by individual with possible dependence in stability across multiple years, 
requiring a multi-level model. A random intercept logistic regression model was used, showing 
individual rather than population effects. Level 1 corresponded to financial years and level 2 to the 
individual. Further details are given in the supplement. 
Univariable Analyses 
Univariable random intercept logistic regression models were generated for each of the candidate 
predictors: age group, deprivation category, ethnicity, primary diagnostic category and gender. 
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Multivariable Analyses 
For the multivariable model, candidate predictors were added in turn and retained if their odds-ratio 
for risk of instability was significantly (p< 0.05) different to 1 or their inclusion improved model fit (a 
decrease of >2 in Schwarz's Bayesian Information Criterion (BIC)
18,19
). Individuals were excluded from 
the model in a given year if, in that year, they had missing data for any of the predictors.  
RESULTS 
Refinement of diagnostic codes indicating LLC 
Codes F80.3 (acquired aphasia with epilepsy (Landau-Kleffner)), Q74.8 (other specified congenital 
malformations of limbs) and Q44.5 (other congenital malformations of bile ducts) were removed 
from the coding framework.  
Missing and conflicting data 
Gender, date of birth and deprivation category were missing or conflicting for less than 1% of 
individuals. Ethnicity was missing for 4620 individuals (22.6%), with 173 conflicts. 
Fewer than 10 individuals had inconsistent dates of death. 60 individuals had dates of death 
discarded due to at least one SBR or SMR01 episode beginning after the last recorded date of death. 
Numbers of CYP with LLC in Scotland 
20436 CYP with a LLC were alive and resident in Scotland between 1 April 2009 and 31 March 2014. 
Numbers increased from 12039 in 2009/2010 to 15404 in 2013/2014 (Table 1). 
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Table 1: Cohort demographics: for demographics that are constant across years, the number of 
individuals over the whole study period is provided; for demographics that do change across years, 
such numbers are not meaninŐĨƵůĂŶĚƚŚĞƐĞĂƌĞŵĂƌŬĞĚ ?E ? ? ? 
Number of persons in 
the cohort 
Financial Year Study period (1 
April 2009 ʹ 30 
March 2014) 
2009/10 2010/11 2011/12 2012/13 2013/14 
Overall cohort 12039 12930 13756 14573 15404 20436 
Age group 
< 1 1163 1085 1087 1055 1096 N/A 
1-5 3470 3552 3637 3683 3687 N/A 
6-10 1887 2330 2729 3146 3452 N/A 
11-15 1664 1748 1844 1992 2086 N/A 
16-20 1818 1960 2068 2212 2388 N/A 
21-25 2037 2255 2391 2485 2695 N/A 
Sex 
Male 6547 6964 7414 7916 8333 11217 
Female 5490 5964 6340 6654 7068 9215 
Deprivation category       
1 (most deprived) 3041 3275 3478 3655 3897 N/A 
2 2588 2780 2961 3199 3370 N/A 
3 2340 2462 2624 2772 2915 N/A 
4 2043 2262 2445 2561 2723 N/A 
5 (least deprived) 2008 2128 2227 2358 2452 N/A 
Ethnic group 
White 8558 9381 10261 11020 11851 14878 
South Asian 257 287 323 350 380 455 
Black 63 65 75 92 107 139 
Mixed/Other 133 172 213 234 280 344 
Unknown 3028 3025 2884 2877 2786 4620 
Primary diagnostic category 
Neurology 1547 1626 1678 1765 1884 N/A 
Haematology 655 723 782 854 905 N/A 
Oncology 1798 1903 1997 2075 2169 N/A 
Metabolic 317 356 395 444 491 N/A 
Respiratory 1219 1292 1347 1405 1441 N/A 
Circulatory 682 750 782 819 855 N/A 
Gastrointestinal 202 210 215 220 220 N/A 
Genitourinary 763 847 900 953 1004 N/A 
Perinatal 1096 1148 1201 1267 1308 N/A 
Congenital 3689 4007 4391 4701 5047 N/A 
Other 71 68 68 70 80 N/A 
11 
 
 
 
Prevalence increased from 75.0 (95% CI 74.3-75.7) per 10,000 population in 2009/2010 to 95.7 (95% 
CI 94.9-96.5) per 10,000 population in 2013/2014 (Supplementary Table S2). Prevalence increased 
for all age groups except under 1 year olds (195.0 per 10,000 population, 95% CI 189.3-200.6 in 
2009/10; 192.1 per 10,000 population, 95% CI 186.3-197.8 in 2013/14)(Table S2). 
Clinical Stage 
Each year, between 2201 and 2310 cohort members (14-19%) had at least one period of instability 
(Table S3). The number of individuals stable for the whole year increased from 9729 in 2009/2010 
(80.8%; 95% CI 80.5-81.2%) to 13203 in 2013/2014 (85.7%; 95% CI 85.4-86.0%) (Figure 2, Table S3). 
Numbers of individuals in all other stages decreased: 1857 individuals were unstable in 2009/10 
compared to 1783 in 2013/2014; 262 were deteriorating in 2009/2010 and 254 in 2013/14; 191 
were dying in 2009/10 and 164 in 2013/14. There were variations by age, deprivation category and 
diagnostic group (Supplemental Figures S2-S4) with under 1 year olds and those in the most 
deprived categories most likely to experience instability, while those with perinatal conditions were 
most likely to be stable. 
Univariable Analyses 
Individuals under 1 year of age were most likely to experience instability, 5.84 (95% CI 5.26-6.48) 
times more likely to experience instability than the 1-5 year old reference group. 6-10 year olds were 
less likely to experience instability (OR 0.60; 95% CI 0.54-0.67) while 11-25 year olds were more 
likely to experience instability (Table 2). 
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Table 2: Unadjusted odds ratios for risk of instability from univariable random intercept logistic 
regression models of instability in each year. Each variable has a separate model. 
 Odds ratio 95% CI P-value Model characteristics 
 
Univariable model: Age group Log-likelihood: -27410.1 
Degrees of freedom: 7 
BIC: 54898.1 
Data used: 68702 observations from 
20436 persons 
< 1 5.84 5.26 6.48 <0.01 
1-5 Ref    
6-10 0.60 0.54 0.67 <0.01 
11-15 1.14 1.02 1.28 0.02 
16-20 1.40 1.25 1.56 <0.01 
21-25 1.24 1.11 1.38 <0.01 
 
Univariable model: Gender Log-likelihood: -28178.7 
Degrees of freedom: 3 
BIC: 56390.86 
Data used: 68690 observations from 
20432 persons 
Male Ref    
Female 1.12 1.03 1.21 <0.01 
 
Univariable model: Ethnicity Log-likelihood: -24482.0 
Degrees of freedom: 5 
BIC: 49018.47 
Data used: 54102 observations from 
15816 persons 
White Ref    
South Asian 1.69 1.34 2.12 <0.01 
Black 2.01 1.31 3.07 <0.01 
Other 1.57 1.19 2.06 <0.01 
 
Univariable model: Deprivation category Log-likelihood: -28097.2 
Degrees of freedom: 6 
BIC: 56261.25 
Data used: 68566 observations from 
20355 persons 
1  W most deprived Ref    
2 1.02 0.92 1.14 0.65 
3 0.92 0.82 1.03 0.13 
4 0.86 0.76 0.96 <0.01 
5  W least deprived 0.81 0.72 0.91 <0.01 
 
Univariable model: Primary diagnostic category Log-likelihood: -27649.8 
Degrees of freedom: 12 
BIC: 55433.32 
Data used: 68702 observations from 
20436 persons 
Neurological 1.68 1.48 1.90 <0.01 
Haematology 1.86 1.58 2.18 <0.01 
Oncology 2.27 2.03 2.55 <0.01 
Metabolic 2.00 1.61 2.47 <0.01 
Respiratory 3.03 2.65 3.45 <0.01 
Circulatory 0.64 0.53 0.78 <0.01 
Gastrointestinal 3.33 2.55 4.34 <0.01 
Genitourinary 2.72 2.35 3.15 <0.01 
Perinatal 0.27 0.23 0.32 <0.01 
Congenital Ref    
Other 1.74 1.08 2.82 0.02 
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Females were 1.12 (95% CI 1.03-1.21) times more likely to experience instability than males. 
Individuals of South Asian (1.69, 95%CI 1.34-2.12 times), Black (2.01, 95% CI 1.31-3.07) or Other 
ethnicity (1.57, 95% CI 1.19-2.06 times) were more likely to experience instability than those of 
White ethnicity. 
There were differences in risk of instability by deprivation category, with the least deprived group 
less likely (0.81, 95% CI 0.72-0.91 times) to experience instability than the most deprived group. 
There were also differences by primary diagnostic category. With congenital conditions as the 
reference category, all other primary diagnostic groups were associated with a higher risk of 
instability except perinatal conditions (OR 0.27, 95% CI 0.23-0.32) and circulatory conditions (OR 
0.64, 95% CI 0.53-0.78). 
Multivariable analyses 
Age category, gender, ethnicity, deprivation category and primary diagnostic category were included 
in the final model (Table 3).  
Table 3: Odds-ratios for risk of instability from multivariable random intercept logistic regression 
models of instability in each year. 
 
Odds ratio 95% CI P-value 
Age group 
<1 6.40 5.74 7.15 < 0.01 
1-5 Ref    
6-10 0.54 0.49 0.60 < 0.01 
11-15 0.73 0.65 0.82 < 0.01 
16-20 0.80 0.71 0.90 < 0.01 
21-25 0.66 0.59 0.75 < 0.01 
Gender 
Male Ref    
Female 1.15 1.06 1.24 < 0.01 
Ethnicity 
White Ref    
South Asian 1.61 1.28 2.01 < 0.01 
Black 1.58 1.04 2.41 0.03 
Other 1.33 1.02 1.74 0.04 
Deprivation category 
1  W most deprived Ref    
14 
 
2 1.09 0.98 1.21 0.13 
3 1.04 0.93 1.16 0.47 
4 0.96 0.86 1.08 0.50 
5 - least deprived 0.93 0.82 1.05 0.22 
Primary diagnostic category 
Neurological 2.53 2.23 2.88 < 0.01 
Haematology 2.41 2.03 2.87 < 0.01 
Oncology 3.75 3.31 4.25 < 0.01 
Metabolic 2.34 1.88 2.91 < 0.01 
Respiratory 3.50 3.06 4.00 < 0.01 
Circulatory 0.89 0.72 1.09 0.25 
Gastrointestinal 5.22 3.91 6.96 < 0.01 
Genitourinary 4.32 3.68 5.07 < 0.01 
Perinatal 0.23 0.19 0.29 < 0.01 
Congenital Ref    
Other 3.11 1.88 5.12 < 0.01 
Model characteristics 
Log likelihood -23173.3 
Degrees of freedom 25 
BIC 46618.92 
Data used 53992 observations for 15756 persons 
 
 
Age was a significant predictor of instability. With 1-5 years as the reference category, under 1 year 
olds had highest risk of instability (OR 6.4, 95% CI 5.7-7.1). Older age groups had lower risk: 6-10 
years OR 0.54 (95% CI 0.49-0.60); 11-15 years OR 0.73 (95% CI 0.65-8-0.82); 16-20 years OR 0.80 
(95% CI 0.71-0.90); 21-25 years OR 0.66 (95% CI 0.59-0.75). 
Instability was significantly more likely for girls than for boys (OR 1.15, 95% CI 1.06-1.24). Instability 
was more likely for CYP of South Asian (OR 1.61, 95% CI 1.28-2.01), Black (OR 1.58, 95% CI 1.04-2.41) 
and Other (OR 1.33, 95% CI 1.02-1.74) than White CYP. 
Deprivation category was not a significant predictor of instability, but inclusion improved model fit 
(as indicated by BIC). 
Primary diagnostic category was a significant predictor of instability. With congenital abnormalities 
as the reference category, most other primary diagnoses indicated a higher risk of instability. Only 
CYP with a Perinatal primary diagnosis had significantly lower risk (OR 0.23, 95% CI 0.19-0.29). 
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Primary Circulatory diagnoses did not indicate significantly different risk to the reference group (OR 
0.89, 95% CI 0.72-1.09). 
As many ethnicity data were missing, a sensitivity analysis was carried out excluding ethnicity from 
the model (Supplemental Table S4). Only circulatory primary diagnoses had an odds ratio for 
instability under this model that was significantly (p<0.05) different to the odds ratio under the 
model including ethnicity. Odds-ratios for other predictors did not differ significantly between the 
two models, although individuals in the most deprived category were significantly more likely than 
those in the least deprived category to experience instability according to the model excluding 
ethnicity  W the two categories were not significantly different in the model including ethnicity. 
DISCUSSION 
This study identified increasing numbers of CYP with LLC living in Scotland, with over 2200 
experiencing at least one episode of instability each year. These individuals may benefit from input 
from specialist paediatric palliative care services. ŚŝůĚƌĞŶ ?Ɛ,ŽƐƉŝĐĞƐƐŽĐŝĂƚŝŽŶ^ĐŽƚůĂŶĚ ?ƚŚĞůĂƌŐĞƐƚ
ƉƌŽǀŝĚĞƌŽĨĐŚŝůĚƌĞŶ ?ƐƉĂůůŝĂƚŝǀĞĐĂƌĞŝŶ^ĐŽƚůĂŶĚ ?ƌĞĐĞŝǀĞĚĂƉƉƌŽǆŝŵĂƚĞůǇ ? ? ?ŶĞǁƌĞĨĞƌƌĂůƐĞĂĐŚǇĞĂƌ
and currently looks after 380 children and families (personal communication). Therefore the 
potential demand for palliative care in the 0-25 year age group in Scotland outstrips the current 
provision. 
Prevalence of CYP with LLC was higher in this study than previous estimates in Scotland and 
England,
1 2
 due to rising prevalence over time and the ability to include individuals alive in Scotland 
with a LLC who did not have a hospital admission in a single year. Prevalence increased in all age 
groups except under 1 year olds suggesting, in common with earlier studies,
1 2 20
 that increased 
prevalence is due to improved survival times rather than increased incidence. 
This is the first study to assign clinical stage based on routinely collected clinical data.  Previous 
approaches have used subjective clinical assessments of care needs, often linked to resource 
usage.
17, 21-25
 This limits assessments to individuals that come into contact with clinicians and may 
16 
 
underestimate the stable fraction. Such estimates can vary widely by location, possibly due to 
differences between individual clinŝĐŝĂŶƐ ? ĂƐƐĞƐƐŵĞŶƚƐ ?21 While the transition criteria used in this 
study were arbitrary, their application to the data was objective and consistent. All CYP identified 
with a LLC were included, whether or not they had any known contact with clinicians in a given year.  
The results from the multivariate analyses highlighted groups with higher risk of instability who may 
therefore benefit from targeted input from paediatric palliative care specialists (e.g., the under 1 age 
group , more than 6 times more likely than any other to experience instability). This input should be 
a combination of direct provisioning of palliative care and training and education of healthcare 
professionals.  
CYP in minority ethnic groups are more likely to experience instability than the White population. 
This may be due to different diagnoses within the same broad diagnostic categories used in the 
model or differences in health-seeking behaviours. There are known differences between ethnic 
groups in prevalence of LLC and critical illness,
1, 2, 26
 diagnoses,
27, 28
 general access to medical 
healthcare and likelihood of hospital admission
29-31
 and access to specialist palliative care 
services.
32,33
 
Deprivation category was not a significant predictor of risk of instability. It has been previously found 
that socioeconomic status did not significantly influence access to healthcare within Britain.
30,34
  
Other than age, the strongest predictors of instability were the diagnostic groups. The low risk of 
instability associated with perinatal diagnoses may reflect inclusion of individuals who had life-
threatening diagnoses/events around the time of birth or in the neonatal period but survived those 
and are no longer life-limited. 
Given that the clinical stage categories are based on clearly defined patterns of healthcare usage 
(e.g. emergency hospital admission or PICU admission) they are useful in identifying clinical areas 
ǁŚĞƌĞŝŶƚĞŐƌĂƚŝŽŶŽĨĐŚŝůĚƌĞŶ ?ƐƉĂůůŝĂƚŝǀĞĐĂƌĞǁŽƵůĚďĞďĞŶĞĨŝĐŝĂů ? 
17 
 
Strengths and Limitations 
This study utilised high quality, linked, national healthcare data. The clinical stage definitions were 
arbitrary but based on clinical knowledge and their application is reproducible and objective. The 
definitions share some similarity with those previously defined,
17
 particularly in emergency 
treatment defining the transition from stable to unstable phases, but differ in defining the 
deteriorating phase using PICU admission and the dying phase using a fixed period before death. 
Cohort identification only required a life-limiting or life-threatening diagnosis to be recorded once 
within the hospital datasets. This may result in including individuals who have had a life-threatening 
event but would no longer be considered life-limited.  
Cohort effects are evident and the lack of availability of the community prescribing data prior to 
2009 may have accounted for some the rise in prevalence and the rise in the number of stable CYP 
with LLC (CYP only present in the prescribing data are, by the definitions used, stable). 
Although this is a national study, small numbers in some of the categories restricted the analyses 
(e.g. clinical stage by ethnic group or on a quarterly rather than yearly basis). It is possible that the 
high number of missing ethnicity data influences the presented association between ethnic group 
and instability, but the sensitivity analysis suggests there is no significant effect on other predictors. 
As ethnicity recording is improving over time, future studies should be undertaken to validate the 
present findings. 
CONCLUSION 
Each year, over 2200 CYP with a LLC in Scotland are unstable, deteriorating or dying and therefore 
would benefit from input from specialist paediatric palliative care services.  
The under 1 age group and CYP of South Asian, Black or Other ethnicities are most likely to be 
unstable, deteriorating or dying and would benefit from targeted input from pediatric palliative care 
specialists. 
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FIGURES 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Criteria for transition between stages of condition for children and young people with a life 
limiting condition in Scotland. The charts at the bottom show two example patient trajectories, with 
multiple changes in clinical stage, and the most severe clinical stage recorded in each year. 
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Figure 2:  Clinical stage among children and young people in Scotland with a life limiting condition. 
Recorded status is the most severe clinical stage in the year. 
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Supplement 
MODEL 
The model used was a random intercept logistic regression model with, in each year, stability (0) or 
instability (1) of an individual as the outcome of predictor variables for that year. Dependence in 
stability/instability outcomes across years for an individual, not explained by the predictors, is 
represented by a random intercept (model constant) for that individual across all years. 
If pij is the probability of an individual i (level 2) experiencing instability in year j (level 1) then: 
loge(pij/(1-pij)) = ɴ1x1ij + ɴ2x2ij A? ? ? + ɴnxnij + Ci + ɸij 
where xnij are predictors (values specific to individual and year), ɴ the corresponding model 
coefficients (not specific to year nor individual), Ci the individual-specific random intercept and ɸij the 
error term specific to individual and year, representing variance not explained by the model. For 
univariable models, there is only one predictor and so only one xij. 
The variables had the following levels: 
x Level 1 (possible variation each year for an individual): 
o Age group 
o Deprivation category 
o Primary diagnostic category 
x Level 2 (constant for an individual across years): 
o Sex 
o Ethnic group 
 
24 
 
TABLES 
Table S1: Datasets used in the study 
Name Purpose Type Coding 
system 
Population coverage Data collection methods 
CHI Community 
Health Index 
The CHI number has been 
mandated as the primary 
patient identifier across 
Scotland.  
Administrative N/A All persons who have 
been registered with a 
Scottish GP 
Most health board patient 
administration and clinical 
systems have been seeded 
with CHI numbers for their 
patients. 
Scottish Birth 
Record 
Records all of a baby's 
neonatal care in Scotland, 
from antenatal through 
to post delivery, including 
readmissions and 
transfers in one 
electronic record. 
Administrative ICD10 All new births in 
Scotland 
Continuous data collection 
Scottish Morbidity 
Record (SMR01) - 
General Acute 
Inpatient and Day 
Case 
Collects episode level 
data on hospital inpatient 
and day case discharges 
from acute specialities 
from hospitals in 
Scotland.  
Administrative ICD10 Covers all residents in 
Scotland that receive 
care in hospital and 
general acute 
specialities. 
Continuous data collection 
Prescribing 
Information 
System 
The definitive data source 
for all prescribing relating 
to all medicines and their 
costs that are prescribed 
and dispensed in the 
community in Scotland.  
 
 
Administrative ICD10 Every prescription 
dispensed in the 
community in Scotland 
Updated monthly 
25 
 
Scottish 
Outpatient 
Dataset 
Collects episode level 
data from patients on 
new and follow up 
appointments at 
outpatient clinics in all 
specialities (except A&E 
and Genito-Urinary 
Medicine). Some 
variation over time and 
between providers on 
recording of follow-up 
appointments.  
Administrative ICD10 The Outpatient 
Attendance dataset 
covers all people 
offered a new or follow 
up outpatient 
appointment at a 
Scottish NHS hospital.  
Continuous data collection 
Scottish Cancer 
Registry 
Responsible for the 
collection of information 
on Scottish residents 
when they are diagnosed 
with malignant (and 
some benign) tumours 
Clinical 
register 
ICD10 Covers all residents in 
Scotland that have had 
a diagnosis of cancer 
Annual returns from 
clinicians 
GRO Death 
registration data 
 
Death records Administrative ICD10 All Deaths occurring in 
Scotland 
 
Continuous data collection 
UK Paediatric 
Intensive Care 
Audit Network 
International audit of 
paediatric intensive care 
which collects data on all 
children admitted to 
paediatric intensive care 
units (PICUs) in the UK 
and Ireland. 
National 
Clinical Audit 
Read 
Codes 
All admissions to PICU 
in the UK and Ireland 
Continuous data collection 
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Table S2: Prevalence of life limiting conditions in children and young people in Scotland throughout 
the study 
 Financial Year 
2009/10 2010/11 2011/12 2012/13 2013/14 
Prevalence per 10000 population (95% CI) 
Age 0-25 75.0 
(74.3-75.7) 
80.2  
(79.5-81.0) 
85.0  
(84.3-85.7) 
90.3  
(89.5-91.0) 
95.7  
(94.9-96.5) 
Age < 1 195.0 
(189.3-200.6) 
182.9  
(177.4-188.4) 
180.1  
(174.7-185.5) 
179.8  
(174.3-185.2) 
192.1  
(186.3-197.8) 
Age 1-5 122.9 
(120.9-125.0) 
123.8 
(121.7-125.8) 
125.9 
(123.8-127.9) 
125.2 
(123.1-127.2) 
124.3 
(122.2-126.3) 
Age 6-10 69.1 
(67.5-70.7) 
86.3 
 (84.5-88.1) 
101.1 
 (99.2-103.1) 
116.0 
(114.0-118.1) 
125.1 
(122.9-127.2) 
Age 11-
15 
54.5 
(53.2-55.8) 
58.0 
(56.6-59.4) 
62.1 
(60.7-63.5) 
68.5 
(67.0-70.1) 
74.0 
(72.4-75.6) 
Age 16-
20 
53.8 
(52.6-55.1) 
57.5 
(56.3-58.8) 
60.7 
(59.4-62.0) 
66.5 
(65.1-67.9) 
73.3 
(71.8-74.8) 
Age 21-
25 
58.7 
(57.4-60.0) 
63.9 
(62.6-65.2) 
66.2 
(64.9-67.6) 
67.7 
(66.4-69.1) 
72.5 
(71.1-73.9) 
 
Table S3: Clinical stage of children and young people in Scotland throughout the study 
Clinical stage Financial Year 
2009/10 2010/11 2011/12 2012/13 2013/14 
Number of persons 
Stable 9729 10678 11485 12310 13203 
Not stable 2310 2252 2271 2263 2201 
Unstable 1857 1816 1822 1834 1783 
Deteriorating 262 253 258 236 254 
Dying 191 183 191 193 164 
% of persons present in year 
Stable  80.8   82.6   83.5   84.5   85.7  
Not stable  19.2   17.4   16.5   15.5   14.3  
Unstable  15.4   14.0   13.2   12.6   11.6  
Deteriorating  2.2   2.0   1.9   1.6   1.6  
Dying  1.6   1.4   1.4   1.3   1.1  
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Table S4: Odds-ratios for risk of instability in each year for children and young people with a life 
limiting condition in Scotland. Odds-ratios obtained from a random intercept logistic regression 
model on a binary outcome variable for the most severe clinical stage in each year: stable (0) or not 
stable (1). Sensitivity analysis excluding ethnic group from the model. 
 
Odds ratio 95% CI P-value 
Age group 
<1 7.20 6.47 8.01 < 0.01 
1-5 Ref    
6-10 0.50 0.45 0.55 < 0.01 
11-15 0.70 0.62 0.78 < 0.01 
16-20 0.73 0.65 0.81 < 0.01 
21-25 0.58 0.52 0.65 < 0.01 
Gender 
Male Ref    
Female 1.12 1.04 1.21 < 0.01 
Deprivation category 
1  W most deprived Ref    
2 1.05 0.95 1.17 0.31 
3 0.97 0.87 1.09 0.64 
4 0.90 0.81 1.01 0.08 
5 - least deprived 0.88 0.79 0.99 0.04 
Primary diagnostic category 
Neurological 2.61 2.29 2.96 < 0.01 
Haematology 2.38 2.02 2.81 < 0.01 
Oncology 3.77 3.34 4.25 < 0.01 
Metabolic 2.15 1.73 2.66 < 0.01 
Respiratory 3.86 3.38 4.41 < 0.01 
Circulatory 0.57 0.48 0.69 < 0.01 
Gastrointestinal 5.15 3.93 6.75 < 0.01 
Genitourinary 4.40 3.77 5.14 < 0.01 
Perinatal 0.19 0.15 0.22 < 0.01 
Congenital Ref    
Other 2.89 1.78 4.67 < 0.01 
Model characteristics 
Log likelihood -26486.66 
Degrees of freedom 22 
BIC 53218.29 
Data used 68554 observations from 20351 persons 
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FIGURES 
 
Figure S1:  Datasets used to form the study cohort and complete patient demographics for prevalence analyses and the process of identifying children and 
young people in Scotland with a life limiting condition. 
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Figure S2: Clinical stage by age group among children and young people in Scotland with a life 
limiting condition. Recorded status is the most severe clinical stage in the year. 
30 
 
 
Figure S3:  Clinical stage by deprivation (SIMD 2009) category among children and young people in 
Scotland with a life limiting condition. Recorded status is the most severe clinical stage in the year. 
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Figure S4:  Clinical stage by diagnostic category among children and young people in Scotland with a 
life limiting condition. Recorded status is the most severe clinical stage in the year. 
 
 
 
